Science ❯ Medical Research ❯ Clinical Trials

Drug Development

FDA Approvals Autism Research NRTIs and Alzheimer's Regulatory T Cells Health Innovations Neurodevelopmental Disorders Innovative Treatments HIV Research Covid-19 Treatments Health Outcomes Innovative Therapies Historical Context Patient Care Immunotherapy Drugs Efficacy Studies Oral Selective Oestrogen Receptor Degraders Larazotide EGFR Mutations Schizophrenia Treatments Oncology Monoclonal Antibodies

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

The novel therapy’s four-receptor approach promises to mirror surgery outcomes with improved tolerability.

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2026 Mina Labs Inc.